4.1 Review

Advancing Cardio-Oncology in Asia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cardiac & Cardiovascular Systems

Opportunities and Challenges in Cardio-Oncology: A Bibliometric Analysis From 2010 to 2022

Shuqing Shi et al.

Summary: Cardio-oncology has rapidly grown as an emerging interdisciplinary discipline worldwide. This bibliometric review used VOSviewer and Citespace software to analyze the literature landscape of cardio-oncology from 2010 to 2022. The analysis identified a total of 1,194 relevant publications in the Web of Science database, showing an increasing trend. The United States dominated the field, with Italy, England, and Canada emerging as significant contributors. The most productive researchers were Ky. Bonnie, Herrmann. Joerg, and Fradley. Michael G. The journal JACC: CardioOncology published the greatest number of papers, focusing on vascular disease, atrial fibrillation, and other research hotspots like immune checkpoint inhibitor-specific cardiovascular toxicity and prevention of cardio-oncology. More research is needed to fill the gap in basic research.

CURRENT PROBLEMS IN CARDIOLOGY (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Cardiac & Cardiovascular Systems

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann et al.

Summary: The discipline of Cardio-Oncology focuses on the cardiovascular care of cancer patients and the management of cardiovascular complications of cancer therapies. This document provides consensus definitions for common cardiovascular toxicities and aims to improve communication and outcomes in clinical practice and research.

EUROPEAN HEART JOURNAL (2022)

Article Oncology

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019

Jonathan M. Kocarnik et al.

Summary: The global burden of cancer is substantial and growing, with differences in burden based on Sociodemographic Index (SDI). The largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles from 2010 to 2019.

JAMA ONCOLOGY (2022)

Article Oncology

Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer

Marilyn L. Kwan et al.

Summary: This study found that breast cancer survivors have a higher risk of heart failure across left ventricular ejection fraction phenotypes, suggesting the need for systematic cardio-oncology surveillance to mitigate this risk in breast cancer patients.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Oncology

Incident Cardiovascular Disease Among Adults With Cancer A Population-Based Cohort Study

D. Ian Paterson et al.

Summary: Patients with cancer are at increased risk for cardiovascular events, including cardiovascular death and nonfatal morbidity. These risks are independent of the site of cancer diagnosis.

JACC: CARDIOONCOLOGY (2022)

Article Oncology

Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship? An English Retrospective Cohort Study

Helen Strongman et al.

Summary: This study investigates the mortality rates of cardiovascular diseases and cancer in cancer survivors and finds that cardiovascular mortality surpasses cancer-specific mortality as survivors get older.

JACC: CARDIOONCOLOGY (2022)

Review Medicine, General & Internal

Cardioprotective effect of Chinese herbal medicine for anthracycline-induced cardiotoxicity in cancer patients: A meta-analysis of prospective studies

Wei Hao et al.

Summary: This study assessed the role of Chinese herbal medicine (CHM) formulations in preventing anthracyclines-induced cardiotoxicity. The results showed that CHM can reduce the occurrence of heart failure. However, due to the insufficient quality of the included trials, the results of this study should be interpreted with caution.

MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

The impact of proton therapy on cardiotoxicity following radiation treatment

Andrew J. Frankart et al.

Summary: Cardiac disease following radiation therapy is a major concern, with damage manifesting in various pathologies related to fibrosis. Minimizing radiation dose to the heart is critical, especially in pediatric patients and when treating disease sites adjacent to the heart. Proton therapy shows promise in reducing dose to normal tissues like the heart.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Article

An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access

Natasha B. Leighl et al.

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Cardiac & Cardiovascular Systems

Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes

Rachel E. Ohman et al.

Summary: Minority and underresourced communities face higher rates of fatal cancer and cardiovascular disease. Disparities in treatment-associated cardiotoxicity show that black breast cancer survivors have elevated risk, while female patients treated with certain drugs have higher risks compared with male patients. Large-scale studies are needed to better understand racial, ethnic, socioeconomic, and gender disparities in cardio-oncology.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Review Cardiac & Cardiovascular Systems

Cardiovascular Safety Assessment in Cancer Drug Development

Ohad Oren et al.

Summary: The development of cardiovascular toxicity due to anticancer drugs is important but underestimated in oncology trials. Reforms and practical strategies are needed to improve cardiovascular safety assessment in cancer drug development.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort study

Jong-Chan Youn et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)

Article Oncology

Cancer burden of major cancers in China: A need for sustainable actions

Maomao Cao et al.

CANCER COMMUNICATIONS (2020)

Review Cardiac & Cardiovascular Systems

Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond

Daniel Addison et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Editorial Material Cardiac & Cardiovascular Systems

The impact of a multidisciplinary cardio-oncology programme on cardiovascular outcomes in Taiwan

Wei-Ting Chang et al.

ESC HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients

Yadi Zhou et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

Cardio-Oncology Education and Training JACC Council Perspectives

Jose A. Alvarez-Cardona et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Oncology

Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study

Yuji Okura et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Preparing the Cardiovascular Workforce to Care for Oncology Patients

Salim S. Hayek et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Precision Cardio-Oncology

Alexandra D. Dreyfuss et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram

Zachi I. Attia et al.

NATURE MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience

Nilesh Pareek et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Review Oncology

Building a Cardio-Onco-Hematology Program

Joerg Herrmann et al.

CURRENT ONCOLOGY REPORTS (2018)

Editorial Material Medicine, General & Internal

Emergence, Development, and Future of Cardio-Oncology in China

Ying Liu et al.

CHINESE MEDICAL JOURNAL (2018)

Review Pharmacology & Pharmacy

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

Luca Falzone et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Medicine, General & Internal

Progress Toward Universal Health Coverage A Comparative Analysis in 5 South Asian Countries

Md. Mizanur Rahman et al.

JAMA INTERNAL MEDICINE (2017)

Article Medicine, General & Internal

Getting the SCOOP - Survey of Cardiovascular Outcomes From Oncology Patients During Survivorship

Nirmanmoh Bhatia et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)

Review Medicine, Research & Experimental

Toward Optimum Benefit-Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles

K. Venkatakrishnan et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2016)

Article Oncology

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry

Melinda L. Telli et al.

BREAST CANCER RESEARCH AND TREATMENT (2011)

Article Medicine, General & Internal

Health in Southeast Asia 1 Health and health-care systems in southeast Asia: diversity and transitions

Virasakdi Chongsuvivatwong et al.

LANCET (2011)

Article Cardiac & Cardiovascular Systems

Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies Are Clinicians Responding Optimally?

Geoffrey J. Yoon et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)